HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Human T-cell leukemia virus type 1 blunts signaling by interferon alpha.

Abstract
Although many animal viruses block the interferon (IFN) signaling pathway, this issue has not been previously investigated in retrovirus-infected cells. For this purpose, an infectious molecular clone of human T-cell leukemia virus type 1 (HTLV-1) was transfected into 293T or HeLa cells and was found to reduce interferon-stimulated response element (ISRE) reporter activity. This effect was independent of expression of the polymerase or envelope products and independent of the ability of Tax to activate the NFkappaB transcriptional pathway. IFN-alpha activation of 6 of 7 endogenous ISRE-regulated genes was also variably reduced, but not IFN-gamma-activated response element-mediated expression of interferon regulatory factor 1. HTLV-1 reduced the phosphorylation of tyrosine kinase 2 (TYK2) and signal transducer and transcriptional activator 2 (STAT2), suggesting a specific effect of HTLV-1 on the ability of an adaptor tyrosine kinase to transfer an IFN signal to the STAT-transcriptional activator complex.
AuthorsXuan Feng, Lee Ratner
JournalVirology (Virology) Vol. 374 Issue 1 Pg. 210-6 (Apr 25 2008) ISSN: 0042-6822 [Print] United States
PMID18234266 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Interferon-alpha
  • STAT2 Transcription Factor
  • STAT2 protein, human
  • Luciferases
  • Protein-Tyrosine Kinases
  • TYK2 Kinase
  • TYK2 protein, human
Topics
  • Cell Line
  • Genes, Reporter
  • Human T-lymphotropic virus 1 (immunology)
  • Humans
  • Interferon-alpha (antagonists & inhibitors)
  • Luciferases (biosynthesis, genetics)
  • Models, Biological
  • Protein-Tyrosine Kinases (antagonists & inhibitors)
  • STAT2 Transcription Factor (metabolism)
  • TYK2 Kinase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: